These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 1575351)

  • 1. Up-and-down regulation of skeletal muscle acetylcholine receptors. Effects on neuromuscular blockers.
    Martyn JA; White DA; Gronert GA; Jaffe RS; Ward JM
    Anesthesiology; 1992 May; 76(5):822-43. PubMed ID: 1575351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basic and clinical pharmacology of the acetylcholine receptor: implications for the use of neuromuscular relaxants.
    Martyn JA
    Keio J Med; 1995 Mar; 44(1):1-8. PubMed ID: 7760531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged d-tubocurarine infusion and/or immobilization cause upregulation of acetylcholine receptors and hyperkalemia to succinylcholine in rats.
    Yanez P; Martyn JA
    Anesthesiology; 1996 Feb; 84(2):384-91. PubMed ID: 8602670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of myasthenic immunoglobulins and cholinergic agonists on acetylcholine receptors of rat myotubes.
    Ashizawa T; Elias SB; Appel SH
    Ann Neurol; 1982 Jan; 11(1):22-7. PubMed ID: 6277235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Train-of-four and tetanic fade are not always a prejunctional phenomenon as evaluated by toxins having highly specific pre- and postjunctional actions.
    Nagashima M; Yasuhara S; Martyn JAJ
    Anesth Analg; 2013 May; 116(5):994-1000. PubMed ID: 23477960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of junctional acetylcholine receptors in myasthenia gravis: clinical correlates.
    Pestronk A; Drachman DB; Self SG
    Muscle Nerve; 1985; 8(3):245-51. PubMed ID: 4058469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged duration of succinylcholine in patients receiving anticonvulsants: evidence for mild up-regulation of acetylcholine receptors?
    Melton AT; Antognini JF; Gronert GA
    Can J Anaesth; 1993 Oct; 40(10):939-42. PubMed ID: 8222033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of postsynaptic plasticity: remodeling of the junctional acetylcholine receptor cluster induced by motor nerve terminal outgrowth.
    Yee WC; Pestronk A
    J Neurosci; 1987 Jul; 7(7):2019-24. PubMed ID: 3302123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromuscular transmission and its pharmacological blockade. Part 1: Neuromuscular transmission and general aspects of its blockade.
    Booij LH
    Pharm World Sci; 1997 Feb; 19(1):1-12. PubMed ID: 9089749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utrophin abundance is reduced at neuromuscular junctions of patients with both inherited and acquired acetylcholine receptor deficiencies.
    Slater CR; Young C; Wood SJ; Bewick GS; Anderson LV; Baxter P; Fawcett PR; Roberts M; Jacobson L; Kuks J; Vincent A; Newsom-Davis J
    Brain; 1997 Sep; 120 ( Pt 9)():1513-31. PubMed ID: 9313636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of acetylcholine receptor loss from the neuromuscular junction.
    Engel AG; Fumagalli G
    Ciba Found Symp; 1982; (90):197-224. PubMed ID: 6923808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pathophysiology of penicillamine-induced myasthenia gravis.
    Kuncl RW; Pestronk A; Drachman DB; Rechthand E
    Ann Neurol; 1986 Dec; 20(6):740-4. PubMed ID: 3813503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetylcholine receptors and myasthenia.
    Lindstrom JM
    Muscle Nerve; 2000 Apr; 23(4):453-77. PubMed ID: 10716755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glia cell line-derived neurotrophic factor regulates the distribution of acetylcholine receptors in mouse primary skeletal muscle cells.
    Yang LX; Nelson PG
    Neuroscience; 2004; 128(3):497-509. PubMed ID: 15381279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in acetylcholinesterase in experimental autoimmune myasthenia gravis and in response to treatment with a specific antisense.
    Blotnick E; Hamra-Amitai Y; Wald C; Brenner T; Anglister L
    Eur J Neurosci; 2012 Oct; 36(8):3077-85. PubMed ID: 22805122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-Deazaadenosine: a therapeutic strategy for myasthenia gravis by decreasing the endocytosis of acetylcholine receptors.
    Kuncl RW; Drachman DB; Adams R; Lehar M
    J Pharmacol Exp Ther; 1993 Nov; 267(2):582-9. PubMed ID: 8246131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies.
    Lindstrom JM; Engel AG; Seybold ME; Lennon VA; Lambert EH
    J Exp Med; 1976 Sep; 144(3):739-53. PubMed ID: 182897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroids induce acetylcholine receptors on cultured human muscle: implications for myasthenia gravis.
    Kaplan I; Blakely BT; Pavlath GK; Travis M; Blau HM
    Proc Natl Acad Sci U S A; 1990 Oct; 87(20):8100-4. PubMed ID: 2236023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agrin-LRP4-MuSK signaling as a therapeutic target for myasthenia gravis and other neuromuscular disorders.
    Ohno K; Ohkawara B; Ito M
    Expert Opin Ther Targets; 2017 Oct; 21(10):949-958. PubMed ID: 28825343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A myasthenia gravis plasma immunoglobulin reduces miniature endplate potentials at human endplates in vitro.
    Burges J; Wray DW; Pizzighella S; Hall Z; Vincent A
    Muscle Nerve; 1990 May; 13(5):407-13. PubMed ID: 2345558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.